Candida Agar is used for isolating and differentiating - PDF document

Candida Agar is used for isolating and differentiating Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 Dextrose 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters Suspend 41.1 grams in 1000 ml distilled water. Heat to boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicans ,although all species may be pathogenic. Pept Some strains of C. parapsilosis , C. krusei and C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicans by germ tube formation (3, 4). Specimen is processed and inoculated directly onto the HiMedia Laboratories Technical Data Cultural ResponseM1602: Cultural characteristics observed after an incubation at 25-30°C for 24- 48 hours. Organism Inoculum Growth Recovery Fluorescence Cultural Response Bacillus subtilis ATCC 6633 50-100 good-luxuriant �=70% negative Candida albicans ATCC 50-100 good-luxuriant �=70% positive Candida krusei ATCC 24408 50-100 good-luxuriant �=70% variable Candida tropicalis ATCC 50-100 good-luxuriant �=70% variable Escherichia coli ATCC 8739 50-100 luxuriant �=70% negative 1.Utz J. P., 1967, Med. Clin. North Am. 51:519-5272.Fung and Liang, 1988, Bull Inf. Lab. Serv. Vet (France), 39/30:13.Goldschmidt, Fung, Grant White and Brown, 1991, J. Clin. Microbiol., 29:1095.4.Murray P. R., Baron J. H., Pfaller M. A., Tenover F. C., and YolkenR. H., (Eds.), 1999, Manual of Clinical Microbiology, Revision : / 201 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 Dextrose 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters Suspend 41.1 grams in 1000 ml distilled water. Heat to boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicans ,although all species may be pathogenic. C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenicCandida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isa nutritionally rich medium, which supports the growth of many yeasts and moulds and is differential for C. albicans.Goldschmidt demonstrated that YM agar with aniline blue could be used to identify C. albicans with high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by C. albicans to produce a fluorescent moiety that , yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients Some strains of C. parapsilosis, C. krusei and C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicansby germ tube formation (3, 4). Specimen is processed and inoculated directly onto the Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 Dextrose 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters Suspend 41.1 grams in 1000 ml distilled water. Heat to boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicansalthough all species may be pathogenic. C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenicCandida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isa nutritionally rich medium, which supports the growth of many yeasts and moulds and is differential for C. albicans .demonstrated that YM agar with aniline blue could be used to identify C. albicans with high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by C. albicans to produce a fluorescent moiety that , yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients Some strains of C. parapsilosis , C. krusei C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicans by germ tube formation (3, 4). Specimen is processed and inoculated directly onto the Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 Dextrose 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters Suspend 41.1 grams in 1000 ml distilled water. Heat to boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicans ,all species may be pathogenic. C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenicCandida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isa nutritionally rich medium, which supports the growth of many yeasts and moulds and is differential for C. albicans .Goldschmidt demonstrated that YM agar with aniline blue could be used to identify C. albicans with high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by C. albicans to produce a fluorescent moiety that , yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients Some strains of C. parapsilosis , C. krusei and C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicans by germ tube formation (3, 4). Specimen is processed and inoculated directly onto the Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters Suspend 41.1 grams in 1000 ml distilled water. Heat to boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicans ,although all species may be pathogenic. C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenicCandida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isa nutritionally rich medium, which supports the growth of many yeasts and moulds and is differential for C. albicans .Goldschmidt demonstrated that YM agar with aniline blue could be used to identify C. albicans with high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by C. albicans to produce a fluorescent moiety that , yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients Some strains of C. parapsilosis , C. krusei and C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicans by germ tube formation (3, 4). Specimen is processed and inoculated directly onto the HiMedia Laboratories Technical Data Cultural ResponseCultural characteristics observed after an incubation at 25-30°C for 24- 48 hours. Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 50-100 good-luxuriant �=70% negative Candida albicans ATCC 50-100 good-luxuriant �=70% positive Candida krusei ATCC 24408 50-100 good-luxuriant �=70% variable Candida tropicalis ATCC 50-100 good-luxuriant �=70% variable Escherichia coli ATCC 8739 50-100 luxuriant �=70% negative 2.Fung and Liang, 1988, Bull Inf. Lab. Serv. Vet (France), 39/30:13.Goldschmidt, Fung, Grant White and Brown, 1991, J. Clin. Microbiol., 29:1095.4.Murray P. R., Baron J. H., Pfaller M. A., Tenover F. C., and YolkenR. H., (Eds.), 1999, Manual of Clinical Microbiology, Revision : / 201 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters purifiec . distilled water. Heat to boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicans ,although all species may be pathogenic. C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenicCandida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isa nutritionally rich medium, which supports the growth of many yeasts and moulds and is differential for C. albicans .Goldschmidt demonstrated that YM agar with aniline blue could be used to identify C. albicans with high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by C. albicans to produce a fluorescent moiety that , yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients Some strains of C. parapsilosis , C. krusei and C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicans by germ tube formation (3, 4). Specimen is processed and inoculated directly onto the Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters purifiec . distilled water. Heat boiling with frequent agitation to dissolve the medium Candidiasis is an acute or sub-acute infection caused by members of the genus Candida , mainly Candida albicans ,although all species may be pathogenic. C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenicCandida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isa nutritionally rich medium, which supports the growth of many yeasts and moulds and is differential for C. albicans .Goldschmidt demonstrated that YM agar with aniline blue could be used to identify C. albicans with high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by C. albicans to produce a fluorescent moiety that , yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients Some strains of C. parapsilosis , C. krusei and C. pulcherrima may give slight fluorescence and that may bedistinguished from C. albicans by germ tube formation (3, 4). Specimen is processed and inoculated directly onto the HiMedia Laboratories Technical Data Cultural ResponseCultural characteristics observed after an incubation at 25-30°C for 24- 48 hours. Organism Inoculum(CFU) Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 50-100 good-luxuriant �=70% negativereaction, nofluorescence Candida albicans ATCC10231 50-100 good-luxuriant �=70% positiveyellow-greenfluorescence Candida krusei ATCC 24408 50-100 good-luxuriant �=70% variable Candida tropicalis ATCC 50-100 good-luxuriant �=70% variable Escherichia coli ATCC 8739 50-100 luxuriant �=70% negative Reference 1.Utz J. P., 1967, Med. Clin. North Am. 51:519-5272.Fung and Liang, 1988, Bull Inf. Lab. Serv. Vet (France), 39/30:13.Goldschmidt, Fung, Grant White and Brown, 1991, J. Clin. Microbiol., 29:1095.4.Murray P. R., Baron J. H., Pfaller M. A., Tenover F. C., and YolkenR. H., (Eds.), 1999, Manual of Clinical Microbiology, Revision : / 201 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters purifiec . water. Heat to boiling with frequent agitation to dissolve the medium Principle And Interpretation Candidiasis is an acute or sub-acute infection caused by members of the genus Candida, mainlyCandida albicansall species may be pathogenic.C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenic Candida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isnutritionally rich medium, which supports the growth of many yeasts and moulds and is differential forC. albicansGoldschmidt demonstrated that YM agar with aniline blue could be used to identifyC. albicanswith high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by Pept, yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients required for the growth of C. albicans. Dextrose is an energy source. Aniline blue is a fluorescentindicator. may give slight fluorescence and that may by germ tube formation (3, 4). Specimen is processed and inoculated directly onto surface of the media. HiMedia Laboratories Technical Data Cultural ResponseCultural characteristics observed after an incubation at 25-30°C for 24- 48 hours. Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 50-100 good-luxuriant �=70% negative Candida albicans ATCC 50-100 good-luxuriant �=70% positive Candida krusei ATCC 24408 50-100 good-luxuriant �=70% variable Candida tropicalis ATCC 50-100 good-luxuriant �=70% variable Escherichia coli ATCC 8739 50-100 luxuriant �=70% negative Reference 1.Utz J. P., 1967, Med. Clin. North Am. 51:519-5272.Fung and Liang, 1988, Bull Inf. Lab. Serv. Vet (France), 39/30:13.Goldschmidt, Fung, Grant White and Brown, 1991, J. Clin. Microbiol., 29:1095.4.Murray P. R., Baron J. H., Pfaller M. A., Tenover F. C., and YolkenR. H., (Eds.), 1999, Manual of Clinical Microbiology, Revision : / 201 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Yeast extract 3.000 Malt extract 3.000 Pept 5.000 10.000 Aniline blue 0.100 Agar 20.000 Final pH ( at 25°C) 6.2±0.2**Formula adjusted, standardized to suit performance parameters purifiec . distilled water. Heat to boiling with frequent agitation to dissolve the medium Principle And Interpretation Candidiasis is an acute or sub-acute infection caused by members of the genus Candida, mainlyCandida albicansall species may be pathogenic.C. albicans produce lesions in the mouth, oesophagus, genitourinary tract, skin, nails,bronchi, lungs and other organs in patients whose normal defense mechanism may have been altered by underlying disease,antimicrobial therapy or immunosuppressive agents (1). Since saprophytic yeast are microscopically similar to the pathogenic Candida Agar was developed as described by Fung and Liang (2), which is a modification of Yeast and Mould Agar. It isnutritionally rich medium, which supports the growth of many yeasts and moulds and is differential forC. albicansGoldschmidt demonstrated that YM agar with aniline blue could be used to identifyC. albicanswith high accuracy andpredictability (3). Aniline blue is a fluorescent indicator, metabolized by Pept, yeast extract and malt extract in the medium provide nitrogen, carbon, vitamins, and otheressential nutrients required for the growth of C. albicans. Dextrose is an energy source. Aniline blue is a fluorescentindicator. may give slight fluorescence and that may by germ tube formation (3, 4). Specimen is processed and inoculated directly onto surface of the media. HiMedia Laboratories Technical Data Cultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Reference 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 02 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she HiMedia Laboratories Technical Data Cultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Reference 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 02 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she HiMedia Laboratories Technical Data Cultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Reference 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 02 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she HiMedia Laboratories Technical Data Cultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Reference 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 02 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not HiMedia Laboratories Technical Data Cultural Response Organism Inoculum(CFU) Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Reference 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 02 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Technical Data HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Reference 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 02 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH Please refer disclaimer Overleaf. User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH Please refer disclaimer Overleaf. HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis Candida albicans ATCC Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH Please refer disclaimer Overleaf. HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC10231 Candida krusei ATCC 24408 Candida tropicalis ATCC1369 Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH Please refer disclaimer Overleaf. HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH Please refer disclaimer Overleaf. HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH Please refer disclaimer Overleaf. User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. she hyfrnsbnpib she prncubs. she prncubs Tse aefnre expiry case nn she kaaek. Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she referrec in inciuicuak safesy casa sheess. User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5272.Funh ane Lianh, 1988, Bull Inf. Lab. Sfsw. Vfu (Fsancf), 39/30:13.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. she hyfrnsbnpib she prncubs. she prncubs Tse aefnre expiry case nn she kaaek.Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpxfsuablisife labpsaupsy pspcfeusfs in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she referrec in inciuicuak safesy casa sheess. User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5273.Gplescinieu, Funh, Gsanu Wiiuf ane Bspxn, 1991, J. Clin. Micspbipl., 29:1095.4.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 Pspcfeusfs Hanebppk 2 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. she hyfrnsbnpib she prncubs. she prncubs Tse aefnre expiry case nn she kaaek.Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpxlabpsaupsy pspcfeusfs in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5274.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 Pspcfeusfs Hanebppk 2 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. she hyfrnsbnpib she prncubs. she prncubs Tse aefnre expiry case nn she kaaek.Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpx pspcfeusfs in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not 1.Uuz J. P., 1967, Mfe. Clin. Npsui An. 51:519.5274.Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy,Rfwisipn : 02 User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not Technical Data Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 0 Usfs nusu fnsusf suiuabiliuy pf uif pspeucu(s) in uifis applicauipn psips up usf. Pspeucus cpnfpsn splfly up uif infpsnauipn cpnuainfe inuiis ane puifs sflaufe HiMfeia™ publicauipns. Tif infpsnauipn cpnuainfe in uiis publicauipn is basfe pn pus sfsfasci ane efwflppnfnuxpsk ane is up uif bfsu pf pus knpxlfehf usuf ane accusauf. HiMfeia™ Labpsaupsifs Pwu Lue sfsfswfs uif sihiu up nakf cianhfs upspfcificauipns ane infpsnauipn sflaufe up uif pspeucus au any uinf. Pspeucus asf npu inufnefe fps iunan ps aninal ps uifsapfuuic usf buufps labpsaupsy,eiahnpsuic, sfsfasci ps fusuifs nanufacuusinh usf pnly, unlfss puifsxisf spfcifife. Suaufnfnus cpnuainfe ifsfin sipule npu Technical Data Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 0 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. she hyfrnsbnpib she prncubs. she prncubs Tse aefnre expiry case nn she kaaek.Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpx fsuablisife labpsaupsy in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs (4,5). Reac she referrec in inciuicuak safesy casa sheess. Usfs nusu fnsusf suiuabiliuy pf uif pspeucu(s) in uifis applicauipn psips up usf. Pspeucus cpnfpsn splfly up uif infpsnauipn cpnuainfe inuiis ane puifs sflaufe HiMfeia™ publicauipns. Tif infpsnauipn cpnuainfe in uiis publicauipn is basfe pn pus sfsfasci ane efwflppnfnuxpsk ane is up uif bfsu pf pus knpxlfehf usuf ane accusauf. HiMfeia™ Labpsaupsifs Pwu Lue sfsfswfs uif sihiu up nakf cianhfs upspfcificauipns ane infpsnauipn sflaufe up uif pspeucus au any uinf. Pspeucus asf npu inufnefe fps iunan ps aninal ps uifsapfuuic usf buufps labpsaupsy,eiahnpsuic, sfsfasci ps fusuifs nanufacuusinh usf pnly, unlfss puifsxisf spfcifife. Suaufnfnus cpnuainfe ifsfin sipule npu Technical Data Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 0 3.Isfnbfsh, H.D. Clinical Micspbiplphy Pspcfeusfs Hanebppk 2 HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceGellingColour and Clarity of prepared mediumReactionpH 1.Fusuifs bipcifnical ane sfsplphical ufsus nusu bf cassife puu fps fusuifs iefnuificauipn. Please refer disclaimer Overleaf. she hyfrnsbnpib she prncubs. she prncubs Tse aefnre expiry case nn she kaaek. Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpx fsuablisife labpsaupsy pspcfeusfs in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical Reference Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicansall spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (1). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (2), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (3). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu flupsfscfncf ane uiau nay by hfsn uubf fpsnauipn (3, 4). Spfcinfn is pspcfssfe ane inpculaufe eisfculy pnup Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she referrec in inciuicuak safesy casa sheess. Please refer disclaimer Overleaf.M1602 Candida Agar Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicans all spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu by hfsn uubf is pspcfssfe ane Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she referrec in inciuicuak safesy casa sheess. Usfs nusu fnsusf suiuabiliuy pf uif pspeucu(s) in uifis applicauipn psips up usf. Pspeucus cpnfpsn splfly up uif infpsnauipn cpnuainfe inuiis ane puifs sflaufe HiMfeia™ publicauipns. Tif infpsnauipn cpnuainfe in uiis publicauipn is basfe pn pus sfsfasci ane efwflppnfnuxpsk ane is up uif bfsu pf pus knpxlfehf usuf ane accusauf. HiMfeia™ Labpsaupsifs Pwu Lue sfsfswfs uif sihiu up nakf cianhfs upspfcificauipns ane infpsnauipn sflaufe up uif pspeucus au any uinf. Pspeucus asf npu inufnefe fps iunan ps aninal ps uifsapfuuic usf buufps labpsaupsy,eiahnpsuic, sfsfasci ps fusuifs nanufacuusinh usf pnly, unlfss puifsxisf spfcifife. Suaufnfnus cpnuainfe ifsfin sipule npu Technical Data Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 0 3.Isfnbfsh, H.D. Clinical Micspbiplphy Pspcfeusfs Hanebppk 2 In vitro diagnostic medicalCE Markingnot use if package is ,Esdoornlaan 13, 3951 IVD 23 Vaeiani Ineususial Esuauf, Usfs nusu fnsusf suiuabiliuy pf uif pspeucu(s) in uifis applicauipn psips up usf. Pspeucus cpnfpsn splfly up uif infpsnauipn cpnuainfe inuiis ane puifs sflaufe HiMfeia™ publicauipns. Tif infpsnauipn cpnuainfe in uiis publicauipn is basfe pn pus sfsfasci ane efwflppnfnuxpsk ane is up uif bfsu pf pus knpxlfehf usuf ane accusauf. HiMfeia™ Labpsaupsifs Pwu Lue sfsfswfs uif sihiu up nakf cianhfs upspfcificauipns ane infpsnauipn sflaufe up uif pspeucus au any uinf. Pspeucus asf npu inufnefe fps iunan ps aninal ps uifsapfuuic usf buufps labpsaupsy,eiahnpsuic, sfsfasci ps fusuifs nanufacuusinh usf pnly, unlfss puifsxisf spfcifife. Suaufnfnus cpnuainfe ifsfin sipule npu Technical Data Mussay P. R., Baspn J. H., Pfallfs M. A., Tfnpwfs F. C., ane YplkfnR. H., (Ees.), 1999, Manual pf Clinical Micspbiplphy, Rfwisipn : 0 3.Isfnbfsh, H.D. Clinical Micspbiplphy Pspcfeusfs Hanebppk 2 In vitro diagnostic medicalnot use if package is ,Esdoornlaan 13, 3951 IVD 23 Vaeiani Ineususial Esuauf, Please refer disclaimer Overleaf.M1602 Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl purifiec . eisuillfe xaufs. Hfau up bpilinh xiui fsfrufnu ahiuauipn up eissplwf uif nfeiun Principle And Interpretation Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus Candida, nainlyCandida albicans all spfcifs nay bf pauiphfnic.C. albicans pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnic Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu isnuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fpsC. albicansGplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuifyC. albicansxiui iihi accusacy anepsfeicuabiliuy (). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by fssfnuial Spnf susains nay hiwf slihiu by hfsn uubf pspcfssfe ane Candida Agar Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she referrec in inciuicuak safesy casa sheess. Usfs nusu fnsusf suiuabiliuy pf uif pspeucu(s) in uifis applicauipn psips up usf. Pspeucus cpnfpsn splfly up uif infpsnauipn cpnuainfe inuiis ane puifs sflaufe HiMfeia™ publicauipns. Tif infpsnauipn cpnuainfe in uiis publicauipn is basfe pn pus sfsfasci ane efwflppnfnuxpsk ane is up uif bfsu pf pus knpxlfehf usuf ane accusauf. HiMfeia™ Labpsaupsifs Pwu Lue sfsfswfs uif sihiu up nakf cianhfs upspfcificauipns ane infpsnauipn sflaufe up uif pspeucus au any uinf. Pspeucus asf npu inufnefe fps iunan ps aninal ps uifsapfuuic usf buufps labpsaupsy,eiahnpsuic, sfsfasci ps fusuifs nanufacuusinh usf pnly, unlfss puifsxisf spfcifife. Suaufnfnus cpnuainfe ifsfin sipule npu Technical Data Rfwisipn : 0 In vitro diagnostic medical CE Markingnot use ,Esdoornlaan 13, 3951 IVD 23 Vaeiani Ineususial Esuauf, HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceReaction Please refer disclaimer Overleaf. she prncubs. she prncubs Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpx fsuablisife labpsaupsy pspcfeusfs in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical Reference 3.Isfnbfsh, H.D. Clinical Micspbiplphy Pspcfeusfs Hanebppk 2 Please refer disclaimer Overleaf.M1602 Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl xaufs. Hfau up bpilinh xiui fsfrufnu up eissplwf uif cpnplfufly. Sufsilizf by auupclawinh au 15 lbs psfssusf (121°C) fps 15 ninuufs.Cppl up 45.50°C. Miy xfll ane ppus inup Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus nainly Caneiea albicans,all spfcifs nay bf pauiphfnic. pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, nails,bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh eisfasf,anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif pauiphfnicCaneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (1), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu is a nuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fps Gplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuify xiui iihi accusacy ane psfeicuabiliuy (2). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by up pspeucf a flupsfscfnu npifuy uiau can Pfpupnf, yfasu fyusacu ane nalu fyusacu in uif nfeiun pspwief niusphfn, casbpn, wiuanins, ane puifs fssfnuial nuusifnus Spnf susains pf C.pasapsilpsis, C.ksusfi nay hiwf slihiu flupsfscfncf ane uiau nay bf eisuinhuisife fspn Candida Agar Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she referrec in inciuicuak safesy casa sheess. HiMedia Laboratories Technical DataCultural Response Organism Inoculum Growth Recovery Fluorescence Bacillus subtilis ATCC 6633 Candida albicans ATCC 10231 Candida krusei ATCC 24408 Candida tropicalis ATCC Escherichia coli ATCC 8739 Quality ControlAppearanceReaction Please refer disclaimer Overleaf. Usfs nusu fnsusf saff eisppsal by auupclawinh ane/ps incinfsauipn pf usfe ps unusablf psfpasauipns pf uiis pspeucu. Fpllpx fsuablisife labpsaupsy pspcfeusfs in eisppsinh pf inffcuipus naufsials ane naufsial uiau cpnfs inup cpnuacu xiui clinical Reference 3.Isfnbfsh, H.D. Clinical Micspbiplphy Pspcfeusfs Hanebppk 2 Usfs nusu fnsusf suiuabiliuy pf uif pspeucu(s) in uifis applicauipn psips up usf. Pspeucus cpnfpsn splfly up uif infpsnauipn cpnuainfe inuiis ane puifs sflaufe HiMfeia™ publicauipns. Tif infpsnauipn cpnuainfe in uiis publicauipn is basfe pn pus sfsfasci ane efwflppnfnuxpsk ane is up uif bfsu pf pus knpxlfehf usuf ane accusauf. HiMfeia™ Labpsaupsifs Pwu Lue sfsfswfs uif sihiu up nakf cianhfs upspfcificauipns ane infpsnauipn sflaufe up uif pspeucus au any uinf. Pspeucus asf npu inufnefe fps iunan ps aninal ps uifsapfuuic usf buufps labpsaupsy,eiahnpsuic, sfsfasci ps fusuifs nanufacuusinh usf pnly, unlfss puifsxisf spfcifife. Suaufnfnus cpnuainfe ifsfin sipule npu Technical Data Rfwisipn : 0 HiMfeia Labpsaupsifs Pwu. Lue. Rfh.pfficf : 23, Vaeiani Ine.Esu., LBS Mash, Munbai.400086, Cusupnfs casf Np.: 022.6116 pfficf : A.516,Sxasuik Disia Businfss Pask,Via Vaeiani Ine. Esu., LBS Mash, Munbai.400086, Ineia. Cusupnfs casf Np.: 022.6147 1919 Enail: In vitro diagnostic medical CE Markingnot use if package is ,Esdoornlaan 13, 3951 IVD 23 Vaeiani Ineususial Esuauf, Please refer disclaimer Overleaf.M1602 Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl xaufs. Hfau up bpilinh xiui fsfrufnu up eissplwf uif cpnplfufly. Sufsilizf by auupclawinh au 15 lbs psfssusf (121°C) fps 15 ninuufs.Cppl up 45.50°C. Miy xfll ane ppus inup Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus nainly Caneiea albicans, spfcifs nay uif npuui, up uif spfcifs, all inffcufe naufsial sipule bf culuusfe pn euplicauf sfus pf nfeia xiui ane xiuipuu anuifunhal ahfnus.Yfasu ane hspxui pf yfasus ane npules ane ahas xiui bluf cpule Pfpupnf, yfasu sfruisfe fps uif hspxui pf C. albicans. Dfyuspsf is an fnfshy spuscf. Anilinf bluf is a flupsfscfnu ineicaups.Spnf susains hiwf slihiu Candida Agar Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she Please refer disclaimer Overleaf.M1602 Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl xaufs. Hfau up bpilinh xiui fsfrufnu up eissplwf uif cpnplfufly. Sufsilizf by auupclawinh au 15 lbs psfssusf (121°C) fps 15 ninuufs.Cppl up 45.50°C. Miy xfll ane ppus inup Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus nainly all spfcifs nay bf pauiphfnic. pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif spfcifs, all inffcufe naufsial sipule bf culuusfe pn euplicauf sfus pf nfeia xiui ane xiuipuu anuifunhal ahfnus.Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (1), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu is a nuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fps Gplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuify xiui iihi accusacy ane psfeicuabiliuy (2). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by up pspeucf a flupsfscfnu npifuy uiau can Pfpupnf, yfasu fyusacu ane nalu fyusacu in uif nfeiun pspwief niusphfn, casbpn, wiuanins, ane puifs fssfnuial nuusifnus sfruisfe fps uif hspxui pf C. albicans. Dfyuspsf is an fnfshy spuscf. Anilinf bluf is a flupsfscfnu ineicaups.Spnf susains pf pasapsilpsis, C.ksusfi nay hiwf slihiu flupsfscfncf ane uiau nay bf eisuinhuisife Candida Agar Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she referrec in inciuicuak safesy casa sheess. Please refer disclaimer Overleaf.M1602 Ingredients Gms / Litre Suspfne 41.1 hsans in 1000 nl xaufs. Hfau up bpilinh xiui fsfrufnu up eissplwf uif cpnplfufly. Sufsilizf by auupclawinh au 15 lbs psfssusf (121°C) fps 15 ninuufs.Cppl up 45.50°C. Miy xfll ane ppus inup Caneieiasis is an acuuf ps sub.acuuf inffcuipn causfe by nfnbfss pf uif hfnus nainly Caneiea albicans, all spfcifs nay bf pauiphfnic. pspeucf lfsipns in uif npuui, pfsppiahus, hfniupusinasy usacu, skin, bspncii, lunhs ane puifs pshans in pauifnus xipsf npsnal efffnsf nfcianisn nay iawf bffn alufsfe by unefslyinh anuinicspbial uifsapy ps innunpsuppsfssiwf ahfnus (). Sincf sapsppiyuic yfasu asf nicspscppically sinilas up uif spfcifs, all inffcufe naufsial sipule bf culuusfe pn euplicauf sfus pf nfeia xiui ane xiuipuu anuifunhal ahfnus.Caneiea Ahas xas efwflppfe as efscsibfe by Funh ane Lianh (1), xiici is a npeificauipn pf Yfasu ane Mpule Ahas. Iu is a nuusiuipnally sici nfeiun, xiici supppsus uif hspxui pf nany yfasus ane npules ane is eifffsfnuial fps Gplescinieu efnpnsusaufe uiau YM ahas xiui anilinf bluf cpule bf usfe up iefnuify xiui iihi accusacy ane psfeicuabiliuy (2). Anilinf bluf is a flupsfscfnu ineicaups, nfuabplizfe by up pspeucf a flupsfscfnu npifuy uiau can Pfpupnf, yfasu fyusacu ane nalu fyusacu in uif nfeiun pspwief niusphfn, casbpn, wiuanins, ane puifs fssfnuial nuusifnus sfruisfe fps uif hspxui pf C. albicans. Dfyuspsf is an fnfshy spuscf. Anilinf bluf is a flupsfscfnu ineicaups.Spnf susains pf pasapsilpsis, C.ksusfi nay hiwf slihiu flupsfscfncf ane uiau nay bf eisuinhuisife Candida Agar Fps clinical sanplfs fpllpx appsppsiauf ufcinirufs fps ianelinh pfs fsuablisife huieflinfs ( Reac she referrec in inciuicuak safesy casa sheess.